Bio Essence Corporation

Total Valuation

Bio Essence Corporation carries a market capitalization of 7.52M, placing it among publicly traded companies globally. Its enterprise value stands at 14.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Bio Essence Corporation currently has 46.81M shares outstanding.

Valuation Ratios

Bio Essence Corporation trades at a trailing price-to-earnings ratio of 7.94. The price-to-sales ratio is 4.14, and the price-to-book ratio stands at 5.40.

Enterprise Valuation

On an enterprise value basis, Bio Essence Corporation trades at an EV/EBITDA multiple of 8.65 and an EV/FCF ratio of 13.19. The EV/Sales ratio of 4.88 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.23 provides insight into valuation relative to core operating earnings.

Financial Position

Bio Essence Corporation maintains a current ratio of 0.38, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 66.94, indicating elevated leverage, while an interest coverage ratio of 1,002.89 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Bio Essence Corporation has paid 20,250.00 in income taxes, reflecting an effective tax rate of 1.32.

Stock Price Statistics

Bio Essence Corporation's stock has gained approximately 108.79121% over the past 52 weeks. The 50-day moving average sits at 0.25, while the 200-day moving average is 0.19.

Income Statement

Over the trailing twelve months, Bio Essence Corporation generated 2.91M in revenue and converted that into 1.52M in net income, yielding earnings per share of 0.03. EBITDA reached 1.64M, while operating income came in at 1.54M.

Balance Sheet

Bio Essence Corporation holds 675.00 in cash and equivalents against 1.57M in total debt, resulting in a net debt position of 56,161.00. Total book value stands at 2.34M, with working capital of -998,524.00 providing operational flexibility.

Cash Flow

Bio Essence Corporation produced 1.08M in operating cash flow over the past twelve months.

Margins

Bio Essence Corporation operates with a gross margin of 69.68, reflecting its pricing power and cost economics. The operating margin of 52.86 and net profit margin of 52.12 provide insight into operational efficiency.

Dividends & Yields

Scores

Bio Essence Corporation posts an Altman Z-Score of -5.19, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.